Latest Insider Transactions at Certara, Inc. (CERT)
This section provides a real-time view of insider transactions for Certara, Inc. (CERT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Certara, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Certara, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 09
2021
|
Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF |
SELL
Open market or private sale
|
Direct |
51,223
-3.9%
|
$1,741,582
$34.33 P/Share
|
Sep 02
2021
|
Craig R. Rayner PRESIDENT, INTEGRATED DRUG DEV |
SELL
Open market or private sale
|
Direct |
54,462
-3.73%
|
$1,906,170
$35.38 P/Share
|
Sep 01
2021
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
30,000
-4.52%
|
$990,000
$33.86 P/Share
|
Sep 01
2021
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
SELL
Open market or private sale
|
Direct |
19,354
-2.86%
|
$658,036
$34.0 P/Share
|
Aug 30
2021
|
Justin Edge PRES., REGULATORY & ACCESS |
SELL
Open market or private sale
|
Direct |
9,000
-2.04%
|
$297,000
$33.5 P/Share
|
Aug 25
2021
|
William F Feehery CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
75,000
-1.19%
|
$2,325,000
$31.23 P/Share
|
Aug 24
2021
|
Jieun W. Choe CHIEF STRATEGY & MARKETING |
SELL
Open market or private sale
|
Direct |
7,500
-2.27%
|
$225,000
$30.0 P/Share
|
Aug 19
2021
|
Jieun W. Choe CHIEF STRATEGY & MARKETING |
SELL
Open market or private sale
|
Direct |
12,500
-3.64%
|
$350,000
$28.34 P/Share
|
Aug 16
2021
|
Justin Edge PRES., REGULATORY & ACCESS |
SELL
Open market or private sale
|
Direct |
5,000
-1.12%
|
$140,000
$28.58 P/Share
|
Aug 16
2021
|
Michael Andrew Schemick CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
66,667
-4.37%
|
$1,866,676
$28.55 P/Share
|
Aug 16
2021
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
8,000
-2.3%
|
$224,000
$28.58 P/Share
|
Aug 11
2021
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
SELL
Open market or private sale
|
Direct |
19,354
-5.4%
|
$522,558
$27.54 P/Share
|
Aug 02
2021
|
Eqt Avatar Parent L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,252,632
-10.95%
|
$188,568,432
$26.0 P/Share
|
Aug 01
2021
|
Nicolette D Sherman CHIEF HUMAN RESOURCES OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
15,620
+38.04%
|
-
|
Aug 01
2021
|
Nancy Killefer |
BUY
Grant, award, or other acquisition
|
Direct |
6,431
+50.0%
|
-
|
Aug 01
2021
|
Cynthia Collins |
BUY
Grant, award, or other acquisition
|
Direct |
6,431
+50.0%
|
-
|
Jul 28
2021
|
William F Feehery CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
75,000
-2.32%
|
$1,950,000
$26.16 P/Share
|
Jul 26
2021
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,000
-0.86%
|
$78,000
$26.27 P/Share
|
Jul 19
2021
|
Michael Andrew Schemick CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
66,667
-8.03%
|
$1,600,008
$24.37 P/Share
|
Jul 01
2021
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
SELL
Open market or private sale
|
Direct |
19,354
-5.12%
|
$541,912
$28.03 P/Share
|
Jul 01
2021
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
BUY
Grant, award, or other acquisition
|
Direct |
5,495
+1.43%
|
-
|
Jun 28
2021
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,000
-0.85%
|
$84,000
$28.38 P/Share
|
Jun 24
2021
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
5,000
-1.4%
|
$130,000
$26.37 P/Share
|
Jun 23
2021
|
William F Feehery CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
75,000
-1.13%
|
$1,950,000
$26.85 P/Share
|
Jun 22
2021
|
Michael Andrew Schemick CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
66,666
-7.43%
|
$1,733,316
$26.94 P/Share
|
Jun 16
2021
|
Justin Edge PRES., REGULATORY & ACCESS |
SELL
Open market or private sale
|
Direct |
5,000
-1.11%
|
$135,000
$27.02 P/Share
|
Jun 15
2021
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
7,059
+50.0%
|
-
|
Jun 14
2021
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
SELL
Open market or private sale
|
Direct |
19,354
-2.49%
|
$522,558
$27.8 P/Share
|
Jun 11
2021
|
Craig R. Rayner PRESIDENT, INTEGRATED DRUG DEV |
SELL
Open market or private sale
|
Direct |
108,924
-8.06%
|
$2,832,024
$26.0 P/Share
|
May 18
2021
|
James E Cashman Iii |
BUY
Grant, award, or other acquisition
|
Direct |
7,059
+1.44%
|
-
|
May 18
2021
|
Sherilyn S Mc Coy Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,059
+1.12%
|
-
|
May 18
2021
|
Mason P Slaine |
BUY
Grant, award, or other acquisition
|
Direct |
7,059
+0.26%
|
-
|
May 18
2021
|
Matthew M Walsh |
BUY
Grant, award, or other acquisition
|
Direct |
7,059
+3.77%
|
-
|
Apr 01
2021
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
BUY
Grant, award, or other acquisition
|
Direct |
18,315
+4.47%
|
-
|
Apr 01
2021
|
Jieun W. Choe CHIEF STRATEGY & MARKETING |
BUY
Grant, award, or other acquisition
|
Direct |
18,315
+5.07%
|
-
|
Apr 01
2021
|
Judith Dickinson Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,905
+6.42%
|
-
|
Apr 01
2021
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
16,484
+4.4%
|
-
|
Apr 01
2021
|
William F Feehery CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
91,575
+2.69%
|
-
|
Apr 01
2021
|
Craig R. Rayner PRESIDENT, INTEGRATED DRUG DEV |
BUY
Grant, award, or other acquisition
|
Direct |
23,810
+4.87%
|
-
|
Apr 01
2021
|
Michael Andrew Schemick CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
34,799
+3.74%
|
-
|
Apr 01
2021
|
Justin Edge PRES., REGULATORY & ACCESS |
BUY
Grant, award, or other acquisition
|
Direct |
23,810
+5.0%
|
-
|
Apr 01
2021
|
Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF |
BUY
Grant, award, or other acquisition
|
Direct |
23,810
+7.84%
|
-
|
Mar 29
2021
|
Eqt Avatar Parent L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,674,151
-11.58%
|
$208,179,624
$24.12 P/Share
|
Dec 15
2020
|
Stephen M. Mc Lean |
BUY
Open market or private purchase
|
Direct |
22,000
+50.0%
|
$506,000
$23.0 P/Share
|
Dec 15
2020
|
Eqt Avatar Parent L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,167,717
-15.91%
|
$297,522,057
$21.62 P/Share
|
Dec 15
2020
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
BUY
Open market or private purchase
|
Direct |
245
+0.07%
|
$5,635
$23.0 P/Share
|
Dec 15
2020
|
James E Cashman Iii |
BUY
Open market or private purchase
|
Direct |
20,000
+4.03%
|
$460,000
$23.0 P/Share
|
Dec 15
2020
|
Matthew M Walsh |
BUY
Open market or private purchase
|
Direct |
5,000
+2.81%
|
$115,000
$23.0 P/Share
|
Dec 10
2020
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
224,033
+39.61%
|
-
|
Dec 10
2020
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
BUY
Other acquisition or disposition
|
Direct |
117,525
+50.0%
|
-
|